论文部分内容阅读
目的骨质疏松症是一种慢性疾病,发病率在全球范围内不断增加,而且经常会导致脆性骨折的发生。目前颈椎前路椎间盘切除融合术(ACDF)和抗骨质疏松治疗的相关性报道较少。本文旨在探讨抗骨质疏松治疗在颈椎前路椎间盘切除融合术的效果。方法回顾性分析从2010年1月到2013年12月行颈椎前路椎间盘切除融合术的患者。患者分为2组,包括抗骨质疏松治疗组(A组)和非抗骨质疏松治疗组(B组)。术前、术后(末次随访)时测量椎间隙高度(HIS)、颈椎曲度(CA)、节段角(SA)、视觉模拟量表(VAS)、骨密度(BMD)、颈部残疾指数(NDI)。结果本研究共纳入59例患者,其中A组31例,B组28例;男23例,女36例。平均年龄为68.1岁。在末次随访时,椎间隙节段、高度和VAS评分有显著性差异。结论抗骨质疏松治疗对60岁以上老年患者的退行性颈椎疾病的治疗是必要的。
Purpose Osteoporosis is a chronic disease with an increasing prevalence worldwide and often leads to the occurrence of brittle fractures. Currently, there are few reports on the correlation between anterior cervical discectomy and fusion (ACDF) and anti-osteoporosis treatment. This article aims to investigate the anti-osteoporosis treatment in anterior cervical discectomy fusion effect. Methods The patients undergoing anterior cervical discectomy and fusion from January 2010 to December 2013 were retrospectively analyzed. Patients were divided into two groups, including anti-osteoporosis treatment group (group A) and non-anti-osteoporosis treatment group (group B). The intervertebral space height (HIS), cervical curvature (CA), segmental angle (SA), visual analog scale (VAS), bone mineral density (BMD), cervical disability index (NDI). Results A total of 59 patients were enrolled in this study, including 31 in group A and 28 in group B; 23 were males and 36 were females. The average age is 68.1 years old. At the final follow-up, there was a significant difference in intervertebral segment, height, and VAS score. Conclusion Anti-osteoporosis treatment is necessary for the treatment of degenerative cervical spondylosis in elderly patients over 60 years old.